Granulomatosis with polyangiitis

Dr Derek Smith and A.Prof Frank Gaillard et al.

Granulomatosis with polyangiitis (GPA), previously known as Wegener granulomatosis, is a multisystem necrotising non-caseating granulomatous c-ANCA positive vasculitis affecting small to medium sized arteries, capillaries and veins, with a predilection for the respiratory system and kidneys 3.

This article discusses GPA in general. For organ specific radiographic features please refer to individual articles:

There is a slight male predilection and onset is typically at approximately 50 years of age 8.

Presentation depends on which organ systems are involved, however upper respiratory tract symptoms are most common 8. Cough and haemoptysis, proteinuria and haematuria as well as systemic symptoms such as anorexia, malaise and fever are also common 9.

Symptoms related to other organ systems are less frequent, due to a corresponding infrequency of involvement (musculoskeletal symptoms, ocular symptoms, skin changes) 9.

Interstitial fibrosis at the bases is usually the first finding, but is usually asymptomatic. Multiple pulmonary nodules, cavitating in 50% cases is the most common and characteristic manifestation. Pleural effusions and mediastinal nodal enlargement are also encountered. 

Focal lesions can give proteinuria and haematuria while diffuse lesions can give acute renal failure.

Causes mucosal ulceration and granulomatous masses within the nasal cavities with adjacent bony and cartilaginous destruction.

Can result in splenic infarction 16-18

It results from an immune mediated vascular injury.

Histologically necrotising granulomas with an associated vasculitis is the dominant feature.

In 90% of cases cANCA (PR3) is positive and the levels correlate with disease activity 8.

The classic triad of organ involvement consists of:

  • lungs: involved in 95% of cases
  • upper respiratory tract / sinuses: 75-90%
  • kidneys: 80%

In terms of extent granulomatosis with polyangiitis can be classified as:

  • classical: full triad
  • limited: not having the full triad
    • usually respiratory tract involvement only
    • renal only involvement has been described but is uncommon 7
  • widespread: additional organ involvement 14

Treatment is typically with cyclophosphamide, methotrexate and/or steroids.

Without treatment, granulomatosis with polyangiitis is rapidly progressive with death usually occurring within a year of diagnosis, with only 10% of patients surviving 2 years 7. Appropriate medical therapy has dramatically increased long term survival 7.

The former name "Wegener granulomatosis" comes from the German pathologist Friedrich Wegener who first described it in 1936 11. Wegener was a member of the Nazi party and it is suspected that he took part in experiments on concentration camp inmates. Following the discovery of his Nazi past the current name "granulomatosis with polyangiitis" has been proposed 15.

General imaging differential considerations include:

Share article

Article information

rID: 2285
Tag: pr3, lungs
Synonyms or Alternate Spellings:
  • Wegener granulomatosis
  • Wegeners granulomatosis
  • Wegener granulomatosis (WG)
  • Wegener's granulomatosis (WG)
  • Granulomatosis with polyangiitis (GPA)
  • Wegener's granulomatosis

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Wegener granuloma...
    Figure 1: gross pathology
    Drag here to reorder.
  • Drag
    Case 1
    Drag here to reorder.
  • Drag
    Wegener granuloma...
    Figure 2: histology - non-caseating granuloma
    Drag here to reorder.
  • Drag
    Case 2: with nasal septal perforation
    Drag here to reorder.
  • Drag
    Case 3
    Drag here to reorder.
  • Drag
     Case 4
    Drag here to reorder.
  • Drag
    Case 4
    Drag here to reorder.
  • Drag
    Case 5: CNS involvement
    Drag here to reorder.
  • Drag
    Case 6: with paranasal and orbital involvement
    Drag here to reorder.
  • Updating… Please wait.

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.